Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00282698 · ClinicalTrials.gov registry record · Phase 3
Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients
A Phase 3 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 400
- Enrollment target
NCT00282698: Completed Phase 3 study, sponsored by Mayo Clinic.
NCT00282698 is a Phase 3 study that has completed, run by Mayo Clinic. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00282698, a Phase 3 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 400 participants
- Enrollment target
Study Summary
Patients with or without diabetes may have high blood sugar levels due to stress response of the body during heart surgery. This study is being done to determine if maintaining normal blood sugar levels during open-heart surgery by using intravenous insulin results in a lesser incidence of death, wound infections in the chest, disturbances of heart rhythm, kidney failure, stroke and prolonged time on the breathing machine (artificial ventilation) within 30 days after surgery.
Interventions
- DRUG Insulin infusion with a goal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2004-07 |
| Est. Completion | 2005-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00282698
The ClinicalTrials.gov registry entry for NCT00282698 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insulin infusion with a goal is the first listed.
NCT00282698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00282698 about?
NCT00282698 is a clinical study titled "Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients". Patients with or without diabetes may have high blood sugar levels due to stress response of the body during heart surgery. This study is being done to determine if maintaining normal blood sugar levels during open-heart surgery by using intravenous insulin results in a lesser incidence of death, wo...
What is the current status of trial NCT00282698?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2004-07. Estimated completion is 2005-05.
What interventions are being tested in trial NCT00282698?
The interventions under investigation include: Insulin infusion with a goal (DRUG).
Who is sponsoring clinical trial NCT00282698?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.